Overexpression of EGFR has been reproducibly detected in a large number of tumor samples and found to act as a strong prognostic indicator in head and neck, ovarian, cervical, bladder and esophageal cancers, correlating to poorer survival rates [88,89]. This evidence concerns the gene EGFR and neoplasm.